Leon van Wouwe | Clinical Innovation Director
Volv Global
Léon van Wouwe is bringing his clinical development and operational experience to Volv Global SA, to help build bridges between the applied data science solutions the Data Science Team develops and the drug developers, clinical researchers, clinicians, and patients. He has over 20 years of experience working for several different pharmaceutical and health technology companies in a variety of global, regional, and local clinical development and operational roles. Throughout his career, Léon has taken a creative, keen interest in tackling the numerous challenges in developing healthcare solutions, engaging and inspiring people and teams to take a strong cross-functional and cross-disciplinary approach to drive forward the development of and access to innovative new treatment options for patients. Born and raised in The Netherlands, Léon holds an MSc Degree in Biology, specialising in Medical Biology, graduating from Leiden University. Besides living in The Netherlands, he has resided and worked in various European countries, including the UK, Germany, and Switzerland. Outside work, his favourite pastimes include skiing, hiking, and water sports which he enjoys with his family and Whippet.
Appearances:
Pre-Congress Workshops - Tuesday 22nd October @ 10:30
WORKSHOP: ElevateHealth: Creating real impact for rare disease Patients [OFFSITE]
How can stakeholders in the healthcare ecosystem solve the complexity together?
This workshop kicks off a joint initiative between Volv Global and Novartis to start up a Big Picture conversation on how we in our healthcare ecosystem can accelerate and optimise patient outcomes and experience throughout the patient journey, taking particular aim at those issues which arise from insufficient coordination across stakeholders and across differences of scale.
This “ElevateHealth” project will attempt to create better understanding of the complex structural and systemic dynamics in the ecosystem at three different levels of stakeholders:
-The Micro level of the individual, i.e., the patient (also including individual physicians and patient representatives)
-The Meso level of healthcare resources, such as healthcare institutions and healthcare systems
-The Macro level of healthcare provision, including payers, insurers, regulators, taking into account impact outside the healthcare systems and its stakeholders, e.g. on society, for employers, non-paid work, etc.
This workshop will focus very tightly on the barriers to adoption of new technology solutions that can add significant value to the healthcare ecosystem. E.g., to improve the diagnosis pathway, access to care, clinician workload and impact on healthcare system for rare diseases. The Novartis part of ElevateHealth will take the form of a parallel workshop outside the World Orphan Drug Congress programme on the evening of Thursday, 24th October, 2024.
If you are part of the healthcare ecosystem, we welcome you to join us and offer your perspectives to the discussion!
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events